Application 200143
- Type
- ANDA
- Sponsor
- BARR LABS DIV TEVA
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | ACAMPROSATE CALCIUM | ACAMPROSATE CALCIUM | TABLET, DELAYED RELEASE;ORAL | 333MG | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 0093-5352 | Acamprosate Calcium | Acamprosate Calcium | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-5352 | Acamprosate Calcium | Acamprosate Calcium | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 0093-5352 | Acamprosate Calcium | Acamprosate Calcium | Teva Pharmaceuticals USA, Inc. | ANDA | Current |
| 42291-104 | Acamprosate Calcium | Acamprosate Calcium | AvKARE, Inc. | ANDA | Current |
| 42291-104 | Acamprosate Calcium | Acamprosate Calcium | AvKARE | ANDA | Current |